Selected research
Industry Research
Probiotics CDMO Service Industry Research Report 2026
Market perspective
The global Probiotics CDMO Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Probiotics CDMO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Probiotics CDMO Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Probiotics CDMO Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Probiotics CDMO Service include Lallemand Health Solutions, Biofarma Group, ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Huro Biotech, CKD BiO Corp, Biose Industrie, Rise Therapeutics and Chr. Hansen, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Probiotics CDMO Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Probiotics CDMO Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Probiotics CDMO Service Market by Company
Lallemand Health Solutions
Biofarma Group
ILDONG Bioscience Co., Ltd.
Bioprox Healthcare
Huro Biotech
CKD BiO Corp
Biose Industrie
Rise Therapeutics
Chr. Hansen
Lonza AG
Exden
JuneYao Group (BioGrowing)
Sacco System
Falorni srl
Inpac Probiotics
Glac Biotech Co., Ltd
Probiotics CDMO Service Segment by Type
Oral Dosage Forms (Capsules And Tablets)
Powders and Granules
Liquid Preparations
Probiotics CDMO Service Segment by Application
Medicines and Health Products
Food
Pet Food
Cosmetics
Probiotics CDMO Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Probiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics CDMO Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Probiotics CDMO Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Dosage Forms (Capsules And Tablets)
- Powders and Granules
- Liquid Preparations
Applications
- Medicines and Health Products
- Food
- Pet Food
- Cosmetics
Companies covered
- Lallemand Health Solutions
- Biofarma Group
- ILDONG Bioscience Co., Ltd.
- Bioprox Healthcare
- Huro Biotech
- CKD BiO Corp
- Biose Industrie
- Rise Therapeutics
- Chr. Hansen
- Lonza AG
- Exden
- JuneYao Group (BioGrowing)
- Sacco System
- Falorni srl
- Inpac Probiotics
- Glac Biotech Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Probiotics CDMO Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oral Dosage Forms (Capsules And Tablets)
- 2.2.3 Powders and Granules
- 2.2.4 Liquid Preparations
- 2.3 Probiotics CDMO Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medicines and Health Products
- 2.3.3 Food
- 2.3.4 Pet Food
- 2.3.5 Cosmetics
- 2.4 Assumptions and Limitations
3 Probiotics CDMO Service Breakdown Data by Type
- 3.1 Global Probiotics CDMO Service Historic Market Size by Type (2021-2026)
- 3.2 Global Probiotics CDMO Service Forecasted Market Size by Type (2027-2032)
4 Probiotics CDMO Service Breakdown Data by Application
- 4.1 Global Probiotics CDMO Service Historic Market Size by Application (2021-2026)
- 4.2 Global Probiotics CDMO Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Probiotics CDMO Service Market Perspective (2021-2032)
- 5.2 Global Probiotics CDMO Service Growth Trends by Region
- 5.2.1 Global Probiotics CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Probiotics CDMO Service Historic Market Size by Region (2021-2026)
- 5.2.3 Probiotics CDMO Service Forecasted Market Size by Region (2027-2032)
- 5.3 Probiotics CDMO Service Market Dynamics
- 5.3.1 Probiotics CDMO Service Industry Trends
- 5.3.2 Probiotics CDMO Service Market Drivers
- 5.3.3 Probiotics CDMO Service Market Challenges
- 5.3.4 Probiotics CDMO Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Probiotics CDMO Service Players by Revenue
- 6.1.1 Global Top Probiotics CDMO Service Players by Revenue (2021-2026)
- 6.1.2 Global Probiotics CDMO Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Probiotics CDMO Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Probiotics CDMO Service Head Office and Area Served
- 6.4 Global Probiotics CDMO Service Players, Product Type & Application
- 6.5 Global Probiotics CDMO Service Manufacturers Established Date
- 6.6 Global Probiotics CDMO Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Probiotics CDMO Service Market Size (2021-2032)
- 7.2 North America Probiotics CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Probiotics CDMO Service Market Size by Country (2021-2026)
- 7.4 North America Probiotics CDMO Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Probiotics CDMO Service Market Size (2021-2032)
- 8.2 Europe Probiotics CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Probiotics CDMO Service Market Size by Country (2021-2026)
- 8.4 Europe Probiotics CDMO Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Probiotics CDMO Service Market Size (2021-2032)
- 9.2 Asia-Pacific Probiotics CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Probiotics CDMO Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Probiotics CDMO Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Probiotics CDMO Service Market Size (2021-2032)
- 10.2 South America Probiotics CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Probiotics CDMO Service Market Size by Country (2021-2026)
- 10.4 South America Probiotics CDMO Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Probiotics CDMO Service Market Size (2021-2032)
- 11.2 Middle East & Africa Probiotics CDMO Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Probiotics CDMO Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Probiotics CDMO Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lallemand Health Solutions
- 12.1.1 Lallemand Health Solutions Company Information
- 12.1.2 Lallemand Health Solutions Business Overview
- 12.1.3 Lallemand Health Solutions Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.1.4 Lallemand Health Solutions Probiotics CDMO Service Product Portfolio
- 12.1.5 Lallemand Health Solutions Recent Developments
- 12.2 Biofarma Group
- 12.2.1 Biofarma Group Company Information
- 12.2.2 Biofarma Group Business Overview
- 12.2.3 Biofarma Group Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.2.4 Biofarma Group Probiotics CDMO Service Product Portfolio
- 12.2.5 Biofarma Group Recent Developments
- 12.3 ILDONG Bioscience Co., Ltd.
- 12.3.1 ILDONG Bioscience Co., Ltd. Company Information
- 12.3.2 ILDONG Bioscience Co., Ltd. Business Overview
- 12.3.3 ILDONG Bioscience Co., Ltd. Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.3.4 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio
- 12.3.5 ILDONG Bioscience Co., Ltd. Recent Developments
- 12.4 Bioprox Healthcare
- 12.4.1 Bioprox Healthcare Company Information
- 12.4.2 Bioprox Healthcare Business Overview
- 12.4.3 Bioprox Healthcare Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.4.4 Bioprox Healthcare Probiotics CDMO Service Product Portfolio
- 12.4.5 Bioprox Healthcare Recent Developments
- 12.5 Huro Biotech
- 12.5.1 Huro Biotech Company Information
- 12.5.2 Huro Biotech Business Overview
- 12.5.3 Huro Biotech Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.5.4 Huro Biotech Probiotics CDMO Service Product Portfolio
- 12.5.5 Huro Biotech Recent Developments
- 12.6 CKD BiO Corp
- 12.6.1 CKD BiO Corp Company Information
- 12.6.2 CKD BiO Corp Business Overview
- 12.6.3 CKD BiO Corp Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.6.4 CKD BiO Corp Probiotics CDMO Service Product Portfolio
- 12.6.5 CKD BiO Corp Recent Developments
- 12.7 Biose Industrie
- 12.7.1 Biose Industrie Company Information
- 12.7.2 Biose Industrie Business Overview
- 12.7.3 Biose Industrie Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.7.4 Biose Industrie Probiotics CDMO Service Product Portfolio
- 12.7.5 Biose Industrie Recent Developments
- 12.8 Rise Therapeutics
- 12.8.1 Rise Therapeutics Company Information
- 12.8.2 Rise Therapeutics Business Overview
- 12.8.3 Rise Therapeutics Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.8.4 Rise Therapeutics Probiotics CDMO Service Product Portfolio
- 12.8.5 Rise Therapeutics Recent Developments
- 12.9 Chr. Hansen
- 12.9.1 Chr. Hansen Company Information
- 12.9.2 Chr. Hansen Business Overview
- 12.9.3 Chr. Hansen Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.9.4 Chr. Hansen Probiotics CDMO Service Product Portfolio
- 12.9.5 Chr. Hansen Recent Developments
- 12.10 Lonza AG
- 12.10.1 Lonza AG Company Information
- 12.10.2 Lonza AG Business Overview
- 12.10.3 Lonza AG Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.10.4 Lonza AG Probiotics CDMO Service Product Portfolio
- 12.10.5 Lonza AG Recent Developments
- 12.11 Exden
- 12.11.1 Exden Company Information
- 12.11.2 Exden Business Overview
- 12.11.3 Exden Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.11.4 Exden Probiotics CDMO Service Product Portfolio
- 12.11.5 Exden Recent Developments
- 12.12 JuneYao Group (BioGrowing)
- 12.12.1 JuneYao Group (BioGrowing) Company Information
- 12.12.2 JuneYao Group (BioGrowing) Business Overview
- 12.12.3 JuneYao Group (BioGrowing) Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.12.4 JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio
- 12.12.5 JuneYao Group (BioGrowing) Recent Developments
- 12.13 Sacco System
- 12.13.1 Sacco System Company Information
- 12.13.2 Sacco System Business Overview
- 12.13.3 Sacco System Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.13.4 Sacco System Probiotics CDMO Service Product Portfolio
- 12.13.5 Sacco System Recent Developments
- 12.14 Falorni srl
- 12.14.1 Falorni srl Company Information
- 12.14.2 Falorni srl Business Overview
- 12.14.3 Falorni srl Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.14.4 Falorni srl Probiotics CDMO Service Product Portfolio
- 12.14.5 Falorni srl Recent Developments
- 12.15 Inpac Probiotics
- 12.15.1 Inpac Probiotics Company Information
- 12.15.2 Inpac Probiotics Business Overview
- 12.15.3 Inpac Probiotics Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.15.4 Inpac Probiotics Probiotics CDMO Service Product Portfolio
- 12.15.5 Inpac Probiotics Recent Developments
- 12.16 Glac Biotech Co., Ltd
- 12.16.1 Glac Biotech Co., Ltd Company Information
- 12.16.2 Glac Biotech Co., Ltd Business Overview
- 12.16.3 Glac Biotech Co., Ltd Revenue in Probiotics CDMO Service Business (2021-2026)
- 12.16.4 Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio
- 12.16.5 Glac Biotech Co., Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst